Table 1.
Demographic and diagnostic information for the Sz and HC groups for the simple pitch MMN and the ascending-pitch MMN (Experiments 1 & 2), with t/chi-square statistics and p-values for group comparisons. Medication is listed in Chlorpromazine (CPZ) equivalents. Dosages primarily from Andreasen et al. (2010), and remaining dosages from Gardner et al. (2010).
| SZ | HC | ||||
|---|---|---|---|---|---|
| Age | 36.07 | ±8.22 | 32.40 | ±10.54 | t(53)=1.40, p=.166 |
| Gender | M 18/F 9 | M 18/F 10 | x2(53)=0.03, p=.853 | ||
| % Right handed | 89% | 100% | x2(53)=2.15, p=.142 | ||
| SES | 29.85 | ±13.37 | 42.25 | ±11.28 | t(53)=3.72, p<.001 |
| Parental SES | 35.80 | ±13.53 | 41.00 | ±10.13 | t(53)=1.62, p=.111 |
| IQ | 102.78 | ±14.06 | 107.00 | ±11.29 | t(53)=1.23, p=.224 |
| MCCB (MATRICS) | 25.81 | ±4.36 | 28.36 | ±3.93 | t(53)=2.26, p=.028 |
| Medication (CPZ mg/day) | 566.98 | ±320.11 | |||
| Length of illness (years) | 13.72 | ±6.85 | |||
| PANSS total | 69.81 | ±13.73 | |||
| PANSS positive | 14.96 | ±4.94 | |||
| PANSS negative | 19.69 | ±6.21 | |||
| SAPS (global items) | 3.59 | ±2.79 | |||
| SAPS (symptom items) | 8.59 | ±9.77 | |||
| SANS (global items) | 12.19 | ±3.86 | |||
| SANS (symptom items) | 37.19 | ±12.15 | |||
| UPSA communication | 7.04 | ±1.71 | |||
| UPSA financial | 8.23 | ±1.77 | |||